3-(2,2,2-trimethylhydrazinium) propion- ate salts for treating ischemic heart disease

Details for Australian Patent Application No. 2008333263 (hide)

Owner Grindeks, a Joint Stock Company

Inventors Kalvins, Ivars; Stonans, Ilmars

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008333263

PCT Pub. Number WO2009/071586

Priority 07122360.6 05.12.07 EP; 07122359.8 05.12.07 EP

Filing date 3 December 2008

Wipo publication date 11 June 2009

International Classifications

A61K 31/205 (2006.01)

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/071586 Priority application(s): WO2009/071586

12 August 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read New medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008333268-Connector with an integrated quick/ connect disconnect and emergency release system

2008333262-Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate